No. As of September 2026, Medivir AB (MVR0.BE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Medivir AB does not pass Musaffa's business and financial screening criteria.
Medivir AB engages in the development of pharmaceuticals products. The company is headquartered in Huddinge, Stockholm and currently employs 10 full-time employees. The firm specializes in protease inhibitor design and nucleoside and nucleotide science, applying it to development of therapies for cancers with unmet medical need. The firm's clinical pipeline consists of remetinostat, a topical histone deacetylase (HDAC) inhibitor in phase II of clinical studies for the treatment of cutaneous T-cell lymphoma (CTCL), birinapant in combination with Keytruda (pembrolizumab) in phase I of clinical studies for the treatment of solid tumors, MIV-818, a nucleotide-based prodrug in phase I of clinical trials for the treatment of liver cancer, and MIV-711, a cathepsin K (CTSK) inhibitor in IIa extension study for the treatment of osteoarthritis. Furthermore, the Company has additional research projects in cooperation with other institutions.
Medivir AB MVR0.BE
€0.11
Last Updated: Oct 03, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
MVR0.BE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Medivir AB is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Medivir AB (MVR0.BE) Chart
Financial Metrics & Statements of Medivir AB (MVR0.BE)
FAQ's for Medivir AB (MVR0.BE)
As of September 2026, Medivir AB MVR0.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medivir AB using these criteria to determine its compliance status.
Muslim investors may consider investing in Medivir AB if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Medivir AB by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Medivir AB may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Medivir AB on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Medivir AB (MVR0.BE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.